Thyrotropin-Releasing Hormone and Growth Hormone-Releasing Factor in the Evaluation of Hypophyseal Function in Children Undergoing CAPD
Hormonal abnormalities are a well-known complication of the uremic syndrome, and it is well established that renal failure may be associated with a variety of endocrine disturbances and alterations in “feed-back control” mechanisms . In uremic adults acquired defects in the hypothalamic-pituitary-target organ axis, manifested by glucose intolerance , decreased potency and reduced testicular size [3–5], and clinical signs of thyroid dysfunction  are well recognized, while in children, particularly prepubertal children, data are minimal [7–10].
KeywordsGrowth Hormone Luteinizing Hormone Chronic Renal Failure Continuous Ambulatory Peritoneal Dialysis Serum Growth Hormone
Unable to display preview. Download preview PDF.
- 10.Oertel PJ, Lichtwald K, Häfner S, Rauh W, Schönberg D, Schärer K (1983) Hypothalamopituitary-gonadal axis in children with chronic renal failure. Kidney Int 24 (Suppl 15): 34–39Google Scholar
- 17.Lim VS, Auletta F, Kathpalia S (1978) Gonadal dysfunction in chronic renal failure. Dial Transplant 7:896–907Google Scholar
- 23.Boero R, Quarello F, Belardi P, Piccoli G (1983) Blunted response to TRH stimulation in CAPD patients. Perit Dial Bull 3:213 (Letter)Google Scholar
- 24.Borges JLC, Blizzard RM, Gelato MC, Furlanetto R, Rogol AD, Evans WS, Vance ML, Kaiser DL, MacLeod RM, Merriam GR, Lorians DL, Spiess J, Rivier J, Vale W, Thorner MO (1983) Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency. Lancet 2:119–124PubMedCrossRefGoogle Scholar
- 27.Scanion MF, Smith BR, Hall R (1978) Thyroid-stimulating hormone: neuroregulation and clinical application (part I). Clin Sci Mol Med 55:1–10Google Scholar